Now showing items 1-1 of 1

    • Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. 

      Bauer, J; Ozden, O; Akagi, N; Carroll, T; Principe, DR; Staudacher, JJ; Spehlmann, ME; Eckmann, L; Grippo, PJ; Jung, B (Springer Verlag, 2015-10-24)
      BACKGROUND: Understanding cell signaling pathways that contribute to metastatic colon cancer is critical to risk stratification in the era of personalized therapeutics. Here, we dissect the unique involvement of mitogenic ...